Form D · Biotechnology
Cell Point, LLC
Centennial, CO · CIK 0001440393
Offering snapshot reported Jun 17, 2021 · SEC filing
- Reported sold
- Yet to sell Offering amount: $3.8M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 16, 2021 | Amendment | $10,623,308 | $2,247,633vs Jul 23, 2020 | 151 | SEC filing |
| Jul 23, 2020 | Amendment | $8,375,675 | No comparison | 96 | SEC filing |
| Oct 5, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 25, 2018 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jan 13, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 25, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 21, 2013 | Amendment | $0 | -$2,286,245vs Aug 27, 2010 | 29 | SEC filing |
| May 24, 2012 | Amendment | $5,000,000 | -$3,076,155vs Apr 26, 2011 | 14 | SEC filing |
| Feb 22, 2012 | Amendment | $2,200,000 | -$5,876,155vs Apr 26, 2011 | 6 | SEC filing |
| Apr 26, 2011 | Amendment | $8,076,155 | $350,190vs Mar 22, 2011 | 63 | SEC filing |
| Mar 22, 2011 | Amendment | $7,725,965 | $771,130vs Mar 4, 2011 | 63 | SEC filing |
| Mar 4, 2011 | Amendment | $6,954,835 | $1,772,100vs Nov 2, 2010 | 52 | SEC filing |
| Nov 2, 2010 | Amendment | $5,182,735 | $0vs Oct 12, 2010 | 48 | SEC filing |
| Oct 12, 2010 | Amendment | $5,182,735 | $2,011,400vs Oct 1, 2010 | 48 | SEC filing |
| Oct 1, 2010 | Amendment | $3,171,335 | $885,090vs Aug 27, 2010 | 33 | SEC filing |
| Aug 27, 2010 | Initial | $2,286,245 | No comparison | 29 | SEC filing |
| Mar 26, 2010 | Amendment | $10,590,250 | $1,041,750vs Jan 7, 2010 | 79 | SEC filing |
| Jan 7, 2010 | Amendment | $9,548,500 | $2,639,340vs Oct 15, 2009 | 70 | SEC filing |
| Oct 15, 2009 | Amendment | $6,909,160 | $1,718,640vs Aug 6, 2009 | 57 | SEC filing |
| Aug 6, 2009 | Amendment | $5,190,520 | $1,089,115vs Apr 8, 2009 | 45 | SEC filing |
| Apr 8, 2009 | Amendment | $4,101,405 | No comparison | Not reported | SEC filing |
| Jul 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-403349
Loans
Source: Form D, filed Jun 17, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jerry Bryant | Executive |
| Jerry Bryant, Jr. | Director, Executive |
| Terry Colip | Executive |
| Greg Colip | Executive |
| F. David Rollo | Executive |
| Frank David Rollo | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7120 E Orchard Rd Suite 350
Centennial, CO, 80111
Centennial, CO, 80111